|
Lymphoid Neoplasia
Citations 101-110 of 299 total displayed.
|
Past content
(since Jan 2009):
|
Safety and efficacy of single-agent lenalidomide in patients with relapsed and refractory multiple myeloma
- Paul Richardson, Sundar Jagannath, Mohamad Hussein, James Berenson, Seema Singhal, David Irwin, Stephanie F. Williams, William Bensinger, Ashraf Z. Badros, Robert Vescio, Laurie Kenvin, Zhinuan Yu, Marta Olesnyckyj, Jerome Zeldis, Robert Knight, and Kenneth C. Anderson
Blood 2009; 114: 772-778.
[Abstract]
[Full text]
[PDF]
Increased risk of monoclonal gammopathy in first-degree relatives of patients with multiple myeloma or monoclonal gammopathy of undetermined significance
- Celine M. Vachon, Robert A. Kyle, Terry M. Therneau, Barbara J. Foreman, Dirk R. Larson, Colin L. Colby, Tara K. Phelps, Angela Dispenzieri, Shaji K. Kumar, Jerry A. Katzmann, and S. Vincent Rajkumar
Blood 2009; 114: 785-790.
[Abstract]
[Full text]
[PDF]
Risk of plasma cell and lymphoproliferative disorders among 14621 first-degree relatives of 4458 patients with monoclonal gammopathy of undetermined significance in Sweden
- Ola Landgren, Sigurdur Y. Kristinsson, Lynn R. Goldin, Neil E. Caporaso, Cecilie Blimark, Ulf-Henrik Mellqvist, Anders Wahlin, Magnus Bjorkholm, and Ingemar Turesson
Blood 2009; 114: 791-795.
[Abstract]
[Full text]
[PDF]
CD4+ T-cell clones recognizing human lymphoma-associated antigens: generation by in vitro stimulation with autologous Epstein-Barr virus–transformed B cells
- Heather M. Long, Jianmin Zuo, Alison M. Leese, Nancy H. Gudgeon, Hui Jia, Graham S. Taylor, and Alan B. Rickinson
Blood 2009; 114: 807-815.
[Abstract]
[Full text]
[PDF]
Follicular lymphomas with and without translocation t(14;18) differ in gene expression profiles and genetic alterations
- Ellen Leich, Itziar Salaverria, Silvia Bea, Andreas Zettl, George Wright, Victor Moreno, Randy D. Gascoyne, Wing-Chung Chan, Rita M. Braziel, Lisa M. Rimsza, Dennis D. Weisenburger, Jan Delabie, Elaine S. Jaffe, Andrew Lister, Jude Fitzgibbon, Louis M. Staudt, Elena M. Hartmann, Hans-Konrad Mueller-Hermelink, Elias Campo, German Ott, and Andreas Rosenwald
Blood 2009; 114: 826-834.
[Abstract]
[Full text]
[PDF]
Extranodal marginal zone lymphoma of the ocular adnexa
- Alexandra Stefanovic and Izidore S. Lossos
Blood 2009; 114: 501-510.
[Abstract]
[Full text]
[PDF]
Impact of risk stratification on outcome among patients with multiple myeloma receiving initial therapy with lenalidomide and dexamethasone
- Prashant Kapoor, Shaji Kumar, Rafael Fonseca, Martha Q. Lacy, Thomas E. Witzig, Suzanne R. Hayman, Angela Dispenzieri, Francis Buadi, P. Leif Bergsagel, Morie A. Gertz, Robert J. Dalton, Joseph R. Mikhael, David Dingli, Craig B. Reeder, John A. Lust, Stephen J. Russell, Vivek Roy, Steven R. Zeldenrust, A. Keith Stewart, Robert A. Kyle, Philip R. Greipp, and S. Vincent Rajkumar
Blood 2009; 114: 518-521.
[Abstract]
[Full text]
[PDF]
Influence of cytogenetics in patients with relapsed or refractory multiple myeloma treated with lenalidomide plus dexamethasone: adverse effect of deletion 17p13
- Donna Reece, Kevin W. Song, Tommy Fu, Birgitte Roland, Hong Chang, Douglas E. Horsman, Adnan Mansoor, Christine Chen, Esther Masih-Khan, Young Trieu, Helene Bruyere, Douglas A. Stewart, and Nizar J. Bahlis
Blood 2009; 114: 522-525.
[Abstract]
[Full text]
[PDF]
RAR 2 expression is associated with disease progression and plays a crucial role in efficacy of ATRA treatment in myeloma
- Siqing Wang, Guido Tricot, Lei Shi, Wei Xiong, Zhaoyang Zeng, Hongwei Xu, Maurizio Zangari, Bart Barlogie, John D. Shaughnessy, Jr, and Fenghuang Zhan
Blood 2009; 114: 600-607.
[Abstract]
[Full text]
[PDF]
Activation of cAMP signaling inhibits DNA damage–induced apoptosis in BCP-ALL cells through abrogation of p53 accumulation
- Elin Hallan Naderi, Harry W. Findley, Ellen Ruud, Heidi Kiil Blomhoff, and Soheil Naderi
Blood 2009; 114: 608-618.
[Abstract]
[Full text]
[PDF]
|
|
